Condor Research supplies research peptides across Europe as reference compounds for laboratory use only. Operated by Atrio Sciences s.r.o. in Slovakia, we test every batch through an independent third-party laboratory in the EU, issue a lot-specific Certificate of Analysis, and ship from an EU warehouse. This page explains what research peptides are, how we document quality, and which flagship compounds and categories you can browse — all framed strictly for in vitro / laboratory research, not for human or veterinary use.
This page is informational and written for laboratory research contexts only. It does not describe human or animal dosing and contains no therapeutic, diagnostic or consumption claims. All materials are supplied for research use only (RUO).
What are research peptides?
Research peptides are short chains of amino acids — typically a few to a few dozen residues — produced as defined reference compounds for use in laboratory and in vitro investigation. Peptides occupy a distinct chemical space between small molecules and large biologics, which is exactly why they are so widely studied as research tools.1 In a research setting, what matters is not a marketing label but whether the material is what it claims to be: the correct sequence, at a verifiable purity, traceable to the lot in your hand.
That is the entire premise of how Condor operates. A research peptide is only useful as a reagent if its identity and purity are characterized analytically, so a serious supplier treats the Certificate of Analysis — not the product photo — as the real specification.
Why buy research peptides from Condor Research in Europe?
The research-compound market is full of purity numbers; the meaningful question is who generated the number and against what method. Condor is built around a single verifiable principle: every batch is tested by an independent third-party laboratory based in the EU (in Czechia) before it is offered, and the result is issued as a per-batch COA tied to that specific lot. We do not rely solely on supplier-provided documentation or on internal testing.
| What you get | How it is established |
|---|---|
| Independent third-party testing | An EU laboratory in Czechia — separate from the seller — characterizes each lot before it is listed. |
| HPLC purity | Identity and purity by high-performance liquid chromatography; the specification is ≥99% for individual compounds, reported per component for blends. |
| Mass-spectrometry identity | For peptides, MS confirms the observed mass matches the expected mass of the sequence. |
| Lot-specific COA | A Certificate of Analysis carrying the batch/lot number, so the data are traceable to the exact material you receive. |
| EU storage & dispatch | Inventory held in our Slovakia warehouse and shipped within the EU, reducing customs friction and transit time. |
| Transparent legal entity | Atrio Sciences s.r.o., IČO 57 669 651, Hornočermánska 1556/76, 949 01 Nitra, Slovakia — a named, registered company, not an anonymous storefront. |
| SDS / CLP under REACH | A Safety Data Sheet with CLP hazard classification is provided where applicable for safe laboratory handling. |
The differentiator is documentation you can verify, not copy you have to trust. The same checklist applies to any vendor — see our guide on how to choose a research peptide supplier in Europe.
A research peptide is only as good as the evidence around it. We treat the COA — independent, lot-specific, method-stated — as the product.
Which research peptides and categories can I browse?
The quality process above applies across the whole catalog. The flagship compounds below are among the most widely referenced in the literature; each links to its product page, where the listing is intended to carry its own batch documentation.
| Compound | Class / format | Research context (preclinical / in vitro) |
|---|---|---|
| BPC-157 | Synthetic pentadecapeptide · 10 mg lyophilised vial | Studied as a cytoprotective agent across gastrointestinal, vascular and musculoskeletal injury models.2 |
| TB-500 | Full-length thymosin β4 (43 aa) · 10 mg lyophilised vial | Investigated for actin sequestration, cell migration and angiogenesis in repair models.34 |
| GHK-Cu | Copper-binding tripeptide (Gly-His-Lys) · vial | Examined in tissue-remodeling and extracellular-matrix research.5 |
| GLOW (GHK-Cu + BPC-157 + TB-500) | Combination blend · vial | A multi-component repair-research blend; purity reported per component. |
| Ipamorelin | Growth-hormone secretagogue · vial | Studied as a selective ghrelin-receptor agonist in GH-axis research. |
| CJC-1295 (no DAC) | GHRH analog · vial | Investigated alongside secretagogues in growth-hormone-axis models. |
| Semax | Neuropeptide (ACTH fragment derivative) · vial | A Russian regulatory neuropeptide studied in neuroprotection research. |
| Epitalon | Khavinson bioregulator tetrapeptide · vial | Examined within the peptide-bioregulator longevity literature. |
All vialled compounds above are supplied at ≥99% HPLC purity for individual compounds, third-party tested with a COA. Evidence for these compounds is overwhelmingly preclinical (in vitro and animal); none is an approved drug.
Browse by category
- Peptides in Vials — lyophilised reference peptides, the core of the catalog.
- Combination Blends — multi-component formats such as GLOW and KLOW, with purity reported per component.
- Encapsulated Compounds — capsule formats for study designs that call for them.
- Growth Hormone Secretagogues — the GH/IGF-axis research family.
- Tissue Repair & Regeneration — BPC-157, TB-500, GHK-Cu, KPV and related compounds.
How are research peptides characterized — and where do the data stop?
We try to be precise rather than impressive. A ≥99% HPLC purity specification describes the chromatographic purity of the target compound for that lot under the laboratory’s method; mass spectrometry confirms identity for peptides. These are analytical measurements for laboratory research. They do not speak to safety, efficacy, or any use in humans or animals, and a COA reflects the tested batch rather than a generic datasheet. Stating those limits is itself part of quality. For the full method and what a COA contains, see Quality & third-party testing.
How does ordering and EU shipping work?
Tested inventory ships from the EU warehouse in Slovakia via Packeta, DPD or DHL, with free shipping on orders of €150 or more, under DAP (Incoterms 2020). Pricing is in EUR. Sales are final B2B transactions (no returns) except where mandatory law requires otherwise. These logistics sit alongside the quality program; they do not change the RUO framing of the materials.
Frequently asked questions
Are research peptides legal in Europe?
Research compounds supplied strictly for laboratory / in vitro use, with appropriate documentation (SDS/CLP under REACH where applicable) and without any human or veterinary use claim, are sold and used as reference materials within the EU. The legal picture depends on the specific compound and on the research-use framing being genuine — not a disclaimer bolted to the footer. Condor maintains the RUO frame consistently across product copy and content, and supplies materials as reagents only, never for consumption. Legality is compound- and context-specific, so researchers remain responsible for compliance in their own jurisdiction.
Do you ship research peptides across the EU?
Yes. Inventory is held in our Slovakia warehouse and dispatched within the EU via Packeta, DPD or DHL, under DAP (Incoterms 2020), with free shipping on orders of €150 or more. EU-based storage and dispatch reduce customs friction and transit time compared with long international shipping.
Are your products third-party tested?
Yes. Every batch is tested by an independent third-party laboratory in the EU (in Czechia) before it is offered. Identity and purity are determined by HPLC (≥99% for individual compounds; per component for blends), peptides are confirmed by mass spectrometry, and each batch ships with a lot-specific Certificate of Analysis traceable to the material you receive.
What does “Research Use Only” mean here?
It means the materials are supplied as reference compounds for laboratory and in vitro investigation only. They are not drugs, foods or cosmetics; they are not for human or veterinary use; and they are not for diagnostic or therapeutic purposes. We do not publish dosing or “how to take” guidance, because that would contradict the RUO frame.
Who is Condor Research, legally?
Condor Research is operated by Atrio Sciences s.r.o., IČO 57 669 651, registered at Hornočermánska 1556/76, 949 01 Nitra, Slovakia, with an EU warehouse and independent EU-based testing. Questions can be directed to info@condorresearch.com.
Where can I learn more before ordering?
Start with the complete reference guide, Research Peptides Explained (2026), then apply the provider-neutral checklist in How to Choose a Research Peptide Supplier in Europe, and review our documented methods on the Quality & third-party testing page.
Start with the catalog
Browse Peptides in Vials, or go straight to a flagship reference compound such as BPC-157, TB-500 or GHK-Cu. Each listing is intended to carry its own batch documentation.
All products supplied by Condor Research (Atrio Sciences s.r.o.) are for research use only / in vitro use. They are not for human or veterinary use, not drugs, foods or cosmetics, and not for diagnostic or therapeutic purposes. Nothing on this page is dosing, medical or consumption advice.
Condor Research · Scientific desk
References
- Lau JL, Dunn MK. Peptide therapeutics: current status and future directions. Drug Discovery Today. 2015. PMID: 25450771. https://pubmed.ncbi.nlm.nih.gov/25450771/
- Sikiric P, et al. Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye’s Stress Coping Response: Progress, Achievements, and the Future. Gut and Liver. 2020. PMID: 31158953. https://pubmed.ncbi.nlm.nih.gov/31158953/
- Tokura Y, et al. Muscle injury-induced thymosin β4 acts as a chemoattractant for myoblasts. Journal of Biochemistry. 2011. PMID: 20880960. https://pubmed.ncbi.nlm.nih.gov/20880960/
- Xue B, et al. Structural basis of thymosin-β4/profilin exchange leading to actin filament polymerization. Proceedings of the National Academy of Sciences. 2014. PMID: 25313062. https://pubmed.ncbi.nlm.nih.gov/25313062/
- Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition. 2008. PMID: 18644225. https://pubmed.ncbi.nlm.nih.gov/18644225/